Abstract:The most fearsome and devastating aspect of cancer is metastasis. One of the important goals of present cancer research is to better understand the molecular mechanism underlying metastasis. So we have been trying to define factors contributing to cancer metastasis and to clone metastasis related genes by exploiting two model systems of cancer metastasis by mRNA differential display. Among the factors contributing to cancer metastasis, we found that the expression of 67 Kda laminin receptors and matrix metalloproteinase (MMP 2 and MMP 9) were positively correlated with cancer metastasis phenotype. Matrix metalloproteinase inhibitors (TIMP 1, TIMP 2, TIMP 3), retinoid acid receptor, interleukin 12, pseudomutant p53 could decrease the metastatic rate of metastatic human lung cancer cell line (PG) in nude mice. And antisense cDNA of vascular endothelial growth factor gene also inhibited the metastatic rate of PG cells. Two model systems of genetically matched non metastatic and metastatic cancer variants were isolated from PG and human prostate carcinoma (PC 3M) by limited dilution, respectively. PG BE1 and PC 3M 1E8 were highly metastatic variants, with 100% metastatic frequency five weeks after subcutaneous inoculation in nude mice, whereas PG LH7 and PC 3M 2B4 were non metastatic. 80 ESTs were obtained by differential display, among which 30 were cloned and sequenced. One novel gene, designed as TMSG 1 (tumor metastasis suppressor gene 1, accession number AF189062) with a full length cDNA of ～2 kb, showed enhanced expression in non metastatic variant PC 3M 2B4 compared with the isogenetic metastatic variant PC 3M 1E8. Its expression showed to have excellent inverse correlation with metastatic potential in the two model systems and human gastrointestinal surgically resected tumor samples. It had one open reading frame of 230aa and the predicted protein had three transmembrane domains. The expression of TMSG 1 was detected by RT PCR in six human common tumors (prostate, colon, lung, breast, ovary and pancreas). TMSG 1 gene located on long arm of chromosome 1 by Electronic PCR and the localization was reconfirmed by PRINS. We hypothesized that TMSG 1 gene was a candidate for metastasis related gene. Another gene we isolated shared 99% identical sequence to human G3BP (Ras GTPase Activating SH3 domain binding protein). The expression of G3BP was stronger in the non metastatic variant PG LH7 than in the highly metastatic variant PG BE1. Northern blotting and Western blotting with a polyclonal G3BP antibody confirmed increased G3BP expression in non metastatic variants (PG LH7, PC 3M 2B4 and PAa) compared with highly metastatic variants (PG BE1, PC 3M 1E8 and PG). Immunohistochemical analysis demonstrated a prominent granular staining pattern of G3BP in cytoplasm. The expression of G3BP was also detected by RT PCR in six human common tumors (prostate, colon, lung, breast, ovary and pancreas). And its expression showed to have excellent inverse correlation with metastatic potential in human gastric cancer samples, but not in colon cancers. So our discovery revealed a significant correlation between reduced G3BP expression and increased likelihood of cancer metastasis.

Biological characteristics of metastatic cancer cells and cloning of human cancer metastasis-related genes